Bropirimine immunotherapy of upper urinary tract carcinoma in situ

Urology

Volumn 48, Issue 1, 1996, Pages 28-32

  Sarosdy, Michael F ^a   Pisters, Louis L ^b   Carroll, Peter R ^b   Benson, Mitchell C ^b   Moon, Timothy D ^b   Lamm, Donald L ^b   Hudson, M'liss A ^b   Lerner, Seth P ^b   Koch, Michael O ^b   Schellhammer, Paul F ^b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BROPIRIMINE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTHRALGIA; ARTICLE; BLADDER CARCINOMA; CANCER IMMUNOTHERAPY; CARCINOMA IN SITU; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RASH; URINARY TRACT CARCINOMA;

EID: 0030200621     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00080-5     Document Type: Article

References (17)

1. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin. 45:1995;8-30.
2. Farrow GM, Utz DC, Rife CC. Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy. Cancer Res. 36:1976;2495-2501.
3. Althausen AF, Prout GR Jr, Dall JJ. Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol. 116:1976;575-580.
4. Farrow GM, Utz DC, Rife CC, Greene LF. Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder. Cancer Res. 37:1977;2794-2798.
5. Herr HW, Whitmore WF Jr. Ureteral carcinoma in situ after successful intravesical therapy for superficial bladder tumors: incidence, possible pathogenesis and management. J Urol. 138:1987;292-294.
6. Herr HW. Durable response of a carcinoma in situ of the renal pelvis to topical bacillus Calmette-Guerin. J Urol. 134:1985;531-532.
7. Ramsey JC, Soloway MS. Instillation of bacillus Calmette-Guerin into the renal pelvis of a solitary kidney for the treatment of transitional cell carcinoma. J Urol. 143:1990;1220-1222.
8. Sharpe JR, Duffy G, Chin JL. Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ. J Urol. 149:1993;457-460.
9. Studer UE, Casanova G, Kraft R, Zingg EJ. Percutaneous BCG perfusion of the upper urinary tract for carcinoma in situ. Prog Clin Biol Res. 350:1990;81-86.
10. Bellman GC, Sweetser P, Smith AD. Complications of intracavitary bacillus Calmette-Guerin after percutaneous resection of upper tract transitional cell carcinoma. J Urol. 151:1994;13-15.
11. Lotzova E, Savary CA, Stringfellow DA. 5-Halo-6-phenyl-pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells. J Immunol. 130:1983;965-969.
12. Lotzova E, Savary CA, Khan A, Stringfellow DA. Stimulation of natural killer cells in two random-bred strains of athymic rats by interferon-inducing pyrimidinone. J Immunol. 132:1984;2566-2570.
13. Wierenga W. Antiviral and other bioactivities of pyrimidinones. Pharmacol Ther. 30:1985;67-89.
14. Sarosdy MF, Lamm DL, Williams RD, Moon TD, Flanigan RC, Crawford ED, Wilks NE, Earhart RH, Merritt JA. Phase I trial of oral bropirimine in superficial bladder cancer. J Urol. 147:1992;31-33.
15. Sarosdy MF, Lowe BA, Schellhammer PF, Lamm DL, Graham SD Jr, Grossman HB, See WA, Peabody JO, Moon TD, Flanigan RC, et al. Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trial. Urology. 48:1996;21-27.
16. Ratliff TL, Palmer JO, McGarr JA, Brown EJ. Intravesical bacillus Calmette-Guerin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guerin. Cancer Res. 47:1987;1762-1766.
17. Eastham JA, Huffman JL. Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors. J Urol. 150:1993;324-325.